UK - November, 16, 2021; Moderna Pharmaceutical announces that it has a specific vaccine (mRNA-1273.529) under test against the Omicron variant in addition to its vaccine booster candidates.
Choose your region
Selecting a region may change the language and promotional content you see on the Adobe Stock web site.